People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Nasal steroids provided the most significant benefit, especially when compared to montelukast. Nasal antihistamines also ...

In people prone to allergies, exposure to pollen and allergens triggers the release of histamine—a chemical responsible for ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

VMPL New Delhi [India] January 22 Allergy season can be a challenging time for many with symptoms such as sneezing a runny ...

your doctor may recommend an OTC steroid nasal spray. They have few side effects and can really improve your stuffy nose. Like antihistamines, doctors usually recommend that you start them a few ...